Alpha DNA Investment Management LLC acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 9,410 shares of the company's stock, valued at approximately $502,000.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Global Retirement Partners LLC raised its position in shares of Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after purchasing an additional 440 shares during the period. UMB Bank n.a. raised its holdings in Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after buying an additional 235 shares during the period. Larson Financial Group LLC raised its holdings in Doximity by 49.4% during the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after buying an additional 250 shares during the period. Optimum Investment Advisors bought a new position in Doximity in the fourth quarter valued at approximately $43,000. Finally, Morse Asset Management Inc acquired a new position in shares of Doximity in the third quarter valued at approximately $46,000. 87.19% of the stock is currently owned by institutional investors.
Insider Transactions at Doximity
In other news, Director Timothy S. Cabral sold 20,000 shares of the firm's stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares in the company, valued at approximately $366,463.20. This trade represents a 75.87 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 37.40% of the stock is currently owned by corporate insiders.
Doximity Stock Up 0.6 %
Shares of NASDAQ DOCS opened at $53.10 on Friday. The business's 50 day moving average price is $63.40 and its two-hundred day moving average price is $55.67. The company has a market cap of $9.91 billion, a PE ratio of 53.10, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21.
Analyst Upgrades and Downgrades
Several research firms recently commented on DOCS. Needham & Company LLC boosted their price objective on shares of Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, February 7th. KeyCorp cut their price target on Doximity from $83.00 to $70.00 and set an "overweight" rating on the stock in a report on Wednesday. Leerink Partnrs upgraded Doximity from a "hold" rating to a "strong-buy" rating in a report on Friday, February 7th. Truist Financial cut their target price on Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a research note on Thursday, April 10th. Finally, Stephens assumed coverage on shares of Doximity in a research note on Friday, December 20th. They set an "equal weight" rating and a $55.00 price target for the company. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $65.00.
Check Out Our Latest Stock Report on Doximity
About Doximity
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Articles
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.